Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Discover the detailed record of transactions filed by Leversage Jill, Director. Insider active across 1 company, notably Aurinia Pharmaceuticals Inc.. Cumulatively, 7 filings have been recorded. Breakdown: 2 buys · 2 sells. Total volume traded: €131k. Activity tracked since 11 May 2021. The latest transaction was filed on 21 November 2024 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
Jill Leversage is a Board Member at Aurinia Pharmaceuticals Inc. She plays a key role in the governance of the company and in strategic decision-making. Her expertise in the pharmaceutical sector is valuable to the board.